FDA Approves Pancreatic Enzyme Product, Pancreaze
Links shared publicly online about this topic.
- 1,243total visits
FDA Approves Pancreatic Enzyme Product, Pancreaze
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Drug, FDA
Most Recently Shared on April 13, 2010 at 3:15 pm By:
FDA Approves Pancreatic Enzyme Product, Pancreaze http://mnt.to/3B8W #pancreaticcancer
Also Shared By:
FDA approves two new pancreatic enzyme products to aid food digestion
fda.gov — “Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved today by the U.S. Food and Drug Administration.” View full resource at fda.gov
Most Recently Shared on March 1, 2012 at 5:13 pm By:
Bernard Farrell Patient Expert
RT @sstrumello: FDA approves two new pancreatic enzyme products to aid food digestion http://t.co/1AoAlwuh
FDA Panel Rejects Cystic Fibrosis Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insufficiency, saying there is not enough evidence that the drug works better than agents already on the market.” View full resource at qualitypointtech.net
Most Recently Shared on January 13, 2011 at 12:01 am By:
FDA Panel Rejects Cystic Fibrosis Drug: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has vot... http://bit.ly/hMGMAE
Medical News: FDA Panel Rejects Cystic Fibrosis Drug - in Gastroenterology, Pancreatic Diseases from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insuffici” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 11:37 pm By:
FDA Panel Rejects Cystic Fibrosis Drug http://bit.ly/hSR3Ue
FDA approves J&JPRD's PANCREAZE NDA
news-medical.net — “Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE" (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the dige” View full resource at news-medical.net
Most Recently Shared on April 15, 2010 at 4:57 am By:
FDA approves J&JPRD's PANCREAZE NDA: Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced ... http://bit.ly/9HsmuA
FDA Approves Pancreatic Enzyme Product, Pancreaze
drugs.com — “Pancreaze (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Pancreaze side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2010 at 11:44 pm By:
FDA Approves Pancreatic Enzyme Product, Pancreaze - http://bit.ly/c6pGCd
Questions and Answers for Healthcare Professionals and the Public: Use an Approved Pancreatic Enzyme Product (PEP)
fda.gov — “FDA is announcing the approval of Pancreaze (pancrelipase), a pancreatic enzyme product (PEP). FDA approved this third PEP after recently approving Creon and Zenpep.” View full resource at fda.gov
Most Recently Shared on April 12, 2010 at 9:44 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDA_Drug_Info: Updated Q&A 4 H/C Professionals & the Public: Use an Approved Pancreatic Enzyme Product. http://bit.ly/PEPtwo
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
smartbrief.com — “Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire” View full resource at smartbrief.com
Most Recently Shared on September 1, 2009 at 3:02 am By:
Clara Song Physician, Doctor, and Pediatrician
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Zenpep approved for exocrine pancreatic insufficiency (EPI) - MPR
empr.com — “The FDA has approved Zenpep (pancrelipase delayed-release capsules, from Eurand N.V.), a pancreatic enzyme product (PEP) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.” View full resource at empr.com
Most Recently Shared on August 31, 2009 at 6:24 pm By:
MPR News: Zenpep approved for exocrine pancreatic insufficiency (EPI): The FDA has approved Zenpep (pan.. http://bit.ly/45RlgT
Medical News: FDA Approves First EPI Drug For Kids - in Gastroenterology, General Gastroenterology from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the marketing of pancrelipase (Zenpep), the first pancreatic enzyme product for patients with cystic fibrosis and other conditions that has been evaluated in both ad” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2009 at 12:38 am By:
FDA Approves First EPI Drug For Kids http://ow.ly/15MSdh
Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis - MPR
empr.com — “Creon (pancrelipase, from Solvay Pharmaceuticals) delayed-release capsules, a pancreatic enzyme product (PEP), has received FDA approval for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions under the new guidelines for this class of drugs.” View full resource at empr.com
Most Recently Shared on May 1, 2009 at 5:06 pm By:
MPR News: Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic f.. http://tinyurl.com/cugjqx
Advertisement
MNT Cystic Fibrosis
@mnt_cysticfibro
FDA Approves Pancreatic Enzyme Product, Pancreaze http://mnt.to/3B8W #cysticfibrosis
1 year ago...